Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × talazoparib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 5 Neoplasm Metastasis 4 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Endometrial Neoplasms 2 mCRPC 1 Wilms Tumor 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hepatoblastoma 1 Hemangiosarcoma 1 Fallopian Tube Neoplasms 1

Interventions

venetoclax 103 Azacitidine 81 Cytarabine 67 Specimen Handling 45 fludarabine 39 Biopsy 30 Decitabine 28 Daunorubicin 27 Cyclophosphamide 26 Injections 24 fludarabine phosphate 22 Granulocyte Colony-Stimulating Factor 22 Idarubicin 20 Stem Cell Transplantation 18 Whole-Body Irradiation 17 CPX-351 16 Busulfan 16 gilteritinib 15 decitabine and cedazuridine drug combination 15 Mycophenolic Acid 13 Melphalan 13 Filgrastim 13 Cladribine 13 Tacrolimus 11 Mitoxantrone 10 Magnetic Resonance Spectroscopy 10 Gemtuzumab 9 revumenib 8 olutasidenib 8 ruxolitinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05101551 2026-04-22

PARPAML

Stanford University

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡